(Q73093194)
Statements
Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines (English)
Nishio K
Ishida T
Arioka H
Kurokawa H
Fukuoka K
Nomoto T
Fukumoto H
Yokote H
1 November 1996